Ticagrelor (60mg): USES, BENEFITS, SIDE EFFECTS AND MORE

TICAGRACE 60MG/90MG: Elevating the Standards in Antiplatelet Treatment

Introducing TICAGRACE 60MG/90MG TICAGRACE, available in 60mg and 90mg dosages, is a groundbreaking antiplatelet medication that significantly advances the treatment of patients with coronary artery disease and those at high risk of thrombotic events. This innovative formulation of Ticagrelor offers a tailored approach to preventing blood clots and safeguarding cardiovascular health.

The Action Mechanism of TICAGRACE 60MG/90MG TICAGRACE operates by selectively inhibiting the P2Y12 adenosine diphosphate (ADP) receptor on platelets, crucial for blood clot formation. This inhibition prevents platelet activation and aggregation, reducing the risk of forming dangerous clots that can lead to heart attacks or strokes. The availability of TICAGRACE in both 60mg and 90mg dosages allows for personalized treatment, matching the therapy intensity to the patient's specific needs and risk profile.

Advantages of TICAGRACE 60MG/90MG TICAGRACE offers a potent and precise approach to reducing thrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. The dual dosage options ensure that treatment can be optimized for efficacy and safety, minimizing the risk of bleeding while providing effective antiplatelet action. TICAGRACE's rapid onset and potent platelet inhibition make it an essential component of modern cardiovascular therapy.

Who Should Use TICAGRACE 60MG/90MG? TICAGRACE is ideal for patients requiring ongoing antiplatelet therapy, particularly those who have experienced ACS or are undergoing procedures like percutaneous coronary intervention (PCI). The medication is tailored for individuals who need a robust strategy to prevent future cardiovascular events, providing a flexible and effective solution to meet diverse patient needs.

Conclusion: TICAGRACE 60MG/90MG - A Paradigm Shift in Antiplatelet Therapy TICAGRACE 60MG/90MG represents a major leap forward in the management of cardiovascular diseases, offering enhanced protection against thrombotic events through its advanced, patient-centric approach. By delivering targeted, potent antiplatelet action, TICAGRACE stands as a cornerstone in the prevention of recurrent cardiovascular incidents, marking a new era in the treatment of patients with increased thrombotic risk.A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668  BUY NOW